MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults

Congratulations to our valued client, MediWound Ltd., on the recent approval of their Biologics License Application (BLA)!
We are proud to have supported them in their data needs for the submission, including a complete ISS and ISE package.
MediWound Ltd.‘s innovative burn care product has the potential to make a significant impact on the lives of patients, and we are grateful to have had the opportunity to be a part of this journey.

Congratulations again to the entire team at MediWound on this incredible achievement!

Click here to learn more >>